Carolin Tumpach

Ms. Carolin Tumpach

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2015 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
MMMariusz Mital
Mariusz Mital
NWNina Wezynfeld
Nina Wezynfeld
TFTomasz Frączyk
Tomasz Frączyk
MWMagdalena Z. Wiloch
Magdalena Z. Wiloch
UWUrszula E. Wawrzyniak
Urszula E. Wawrzyniak
SDSimon C. Drew
Simon C. Drew

26 January 2022 in Science Translational Medicine
Verified
Journal Article
Closed access
TUThomas S. Uldrick
Thomas S. Uldrick
SAScott V. Adams
Scott V. Adams
RFRemi Fromentin
Remi Fromentin
MRMichael Roche
Michael Roche
SFSteven P. Fling
Steven P. Fling
Sharon LewinSharon Lewin
Sharon Lewin
In people living with HIV (PLWH) on antiretroviral therapy (ART), virus persists in a latent form where there is minimal transcription or protein expression. Latently infected cells are a major barrier to curing HIV. Increasing HIV transcription and viral production in latently infected cells could facilitate immune recognition and reduce the pool of infected cells that persist on ART. Given that programmed cell death protein 1 (PD-1) expressing CD4 + T cells are preferentially infected with HIV in PLWH on ART, we aimed to determine whether administration of antibodies targeting PD-1 would reverse HIV latency in vivo. We therefore evaluated the impact of intravenous administration of pembrolizumab every 3 weeks on HIV latency in 32 PLWH and cancer on ART. After the first infusion of anti–PD-1, we observed a median 1.32-fold increase in unspliced HIV RNA and 1.61-fold increase in unspliced RNA:DNA ratio in sorted blood CD4 + T cells compared to baseline. We also observed a 1.65-fold increase in plasma HIV RNA. The frequency of CD4 + T cells with inducible virus evaluated using the tat/rev limiting dilution assay was higher after 6 cycles compared to baseline. Phylogenetic analyses of HIV env sequences in a participant who developed low concentrations of HIV viremia after 6 cycles of pembrolizumab did not demonstrate clonal expansion of HIV-infected cells. These data are consistent with anti–PD-1 being able to reverse HIV latency in vivo and support the rationale for combining anti–PD-1 with other interventions to reduce the HIV reservoir.

4 October 2022 in Cell Reports Medicine
Verified
Journal Article
Open access
TRThomas A. Rasmussen
Thomas A. Rasmussen
JZJennifer M. Zerbato
Jennifer M. Zerbato
ARAjantha Rhodes
Ajantha Rhodes
CTCarolin Tumpach
Carolin Tumpach
ADAshanti Dantanarayana
Ashanti Dantanarayana
Sharon LewinSharon Lewin
Sharon Lewin
Programmed cell death 1 (PD1) and cytotoxic T lymphocyte-associated protein 4 (CTLA4) suppress CD4+ T cell activation and may promote latent HIV infection. By performing leukapheresis (n = 21) and lymph node biopsies (n = 8) in people with HIV on antiretroviral therapy (ART) and sorting memory CD4+ T cells into subsets based on PD1/CTLA4 expression, we investigate the role of PD1 and CTLA 4 in HIV persistence. We show that double-positive (PD1+CTLA4+) cells in blood contain more HIV DNA compared with double-negative (PD1−CTLA4−) cells but still have a lower proportion of cells producing multiply spliced HIV RNA after stimulation as well as reduced upregulation of T cell activation and proliferation markers. Transcriptomics analyses identify differential expression of key genes regulating T cell activation and proliferation with MAF, KLRB1, and TIGIT being upregulated in double-positive compared with double-negative cells, whereas FOS is downregulated. We conclude that, in addition to being enriched for HIV DNA, double-positive cells are characterized by negative signaling and a reduced capacity to respond to stimulation, favoring HIV latency.

7 August 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CHCathryn L. Haigh
Cathryn L. Haigh
CTCarolin Tumpach
Carolin Tumpach
SDSimon C Drew
Simon C Drew
SCSteven J Collins
Steven J Collins
Internal cleavage of the cellular prion protein generates two well characterised N-terminal fragments, N1 and N2. These fragments have been shown to bind to anionic phospholipids at low pH. We sought to investigate binding with other lipid moieties and queried how such interactions could be relevant to the cellular functions of these fragments. Both N1 and N2 bound phosphatidylserine (PS), as previously reported, and a further interaction with phosphatidic acid (PA) was also identified. The specificity of this interaction required the N-terminus, especially the proline motif within the basic amino acids at the N-terminus, together with the copper-binding region (unrelated to copper saturation). Previously, the fragments have been shown to be protective against cellular stresses. In the current study, serum deprivation was used to induce changes in the cellular lipid environment, including externalisation of plasma membrane PS and increased cellular levels of PA. When copper-saturated, N2 could reverse these changes, but N1 could not, suggesting that direct binding of N2 to cellular lipids may be part of the mechanism by which this peptide signals its protective response.

24 March 2018 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
SCSteven J. Collins
Steven J. Collins
CTCarolin Tumpach
Carolin Tumpach
BGBradley Groveman
Bradley Groveman
SDSimon C. Drew
Simon C. Drew
CHCathryn L. Haigh
Cathryn L. Haigh
Neurogenesis continues in the post-developmental brain throughout life. The ability to stimulate the production of new neurones requires both quiescent and actively proliferating pools of neural stem cells (NSCs). Actively proliferating NSCs ensure that neurogenic demand can be met, whilst the quiescent pool makes certain NSC reserves do not become depleted. The processes preserving the NSC quiescent pool are only just beginning to be defined. Herein, we identify a switch between NSC proliferation and quiescence through changing intracellular redox signalling. We show that N-terminal post-translational cleavage products of the prion protein (PrP) induce a quiescent state, halting NSC cellular growth, migration, and neurite outgrowth. Quiescence is initiated by the PrP cleavage products through reducing intracellular levels of reactive oxygen species. First, inhibition of redox signalling results in increased mitochondrial fission, which rapidly signals quiescence. Thereafter, quiescence is maintained through downstream increases in the expression and activity of superoxide dismutase-2 that reduces mitochondrial superoxide. We further observe that PrP is predominantly cleaved in quiescent NSCs indicating a homeostatic role for this cascade. Our findings provide new insight into the regulation of NSC quiescence, which potentially could influence brain health throughout adult life.

11 April 2015 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
SCSteven J Collins
Steven J Collins
CTCarolin Tumpach
Carolin Tumpach
QLQiao-Xin Li
Qiao-Xin Li
VLVictoria Lewis
Victoria Lewis
TRTimothy M Ryan
Timothy M Ryan
CHCathryn L. Haigh
Cathryn L. Haigh
The beta-amyloid (Aβ) peptide and the Aβ-oligomer receptor, prion protein (PrP), both influence neurogenesis. Using in vitro murine neural stem cells (NSCs), we investigated whether Aβ and PrP interact to modify neurogenesis. Aβ imparted PrP-dependent changes on NSC self-renewal, with PrP-ablated and wild-type NSCs displaying increased and decreased cell growth, respectively. In contrast, differentiation of Aβ-treated NSCs into mature cells was unaffected by PrP expression. Such marked PrP-dependent differences in NSC growth responses to Aβ provides further evidence of biologically significant interactions between these two factors and an important new insight into regulation of NSC self-renewal in vivo.